Insider Shareholders with Direct Ownership of Bristol Myers Squibb CO (BMY)
This section provides a comprehensive overview of the insiders with direct ownership of Bristol Myers Squibb CO (BMY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BRISTOL MYERS SQUIBB CO Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Lamberto Andreotti
Director |
1,318,610 | 634,620 | 935,571 $52.2 Million | 32 |
Apr 07, 2017
Reduced 1.78%
|
|
Giovanni Caforio
Executive Chair of the Board |
1,870,011 | 1,512,454 | 432,266 $24.1 Million | 42 |
Mar 10, 2024
Reduced 9.93%
|
|
Sandra Leung
EVP, General Counsel |
1,104,165 | 978,626 | 347,385 $19.4 Million | 32 |
Mar 10, 2024
Reduced 3.26%
|
|
Francis M Cuss
EVP & CSO |
117,414 | 61,542 | 321,905 $18 Million | 8 |
Mar 10, 2017
Reduced 7.17%
|
|
David V Elkins
EVP, Chief Financial Officer |
660,622 | 465,654 | 194,968 $10.9 Million | 37 |
Mar 10, 2024
Reduced 6.41%
|
|
Charles A Bancroft
EVP, Head of Integration |
557,040 | 578,382 | 137,534 $7.67 Million | 26 |
Mar 10, 2020
Reduced 12.98%
|
|
Christopher S. Boerner
Chief Executive Officer |
277,422 | 176,217 | 101,205 $5.64 Million | 25 |
Mar 10, 2024
Reduced 12.13%
|
|
John E Elicker
EVP, Investor Relations |
101,283 | 83,010 | 70,945 $3.96 Million | 21 |
Mar 10, 2020
Reduced 6.94%
|
|
Samit Hirawat
EVP,Chief Med.Offr.,Drug Dev. |
134,033 | 73,754 | 60,279 $3.36 Million | 16 |
Mar 10, 2024
Reduced 13.95%
|
|
Murdo Gordon
EVP, Chief Commercial Officer |
97,117 | 49,023 | 49,423 $2.76 Million | 16 |
Aug 01, 2018
Reduced 1.48%
|
|
Rupert Vessey
EVP & President, Research |
738,576 | 690,825 | 47,751 $2.66 Million | 51 |
May 03, 2023
Reduced 51.34%
|
|
Joseph C Caldarella
SVP & Controller |
42,061 | 42,087 | 46,297 $2.58 Million | 9 |
Sep 06, 2017
Reduced 16.79%
|
|
Nadim Ahmed
EVP and President, Hematology |
63,197 | 24,308 | 38,889 $2.17 Million | 13 |
Dec 31, 2020
Reduced 16.46%
|
|
Anne Nielsen
Chief Compliance & Ethics Off |
28,081 | 40,205 | 37,973 $2.12 Million | 11 |
Sep 03, 2017
Reduced 2.16%
|
|
Theodore R. Samuels Ii
Director |
35,500 | 0 | 35,500 $1.98 Million | 5 |
Nov 20, 2023
Added 19.32%
|
|
Elizabeth Mily
EVP, Strategy & BD |
60,132 | 25,398 | 34,734 $1.94 Million | 10 |
Apr 01, 2023
Reduced 3.18%
|
|
Louis S Schmukler
EVP,Pres.,Glob.Prod. & Supply |
204,605 | 194,867 | 31,956 $1.78 Million | 20 |
May 10, 2021
Reduced 31.94%
|
|
Ann Powell
EVP, Chief Human Resources |
282,016 | 262,495 | 27,868 $1.55 Million | 26 |
Aug 24, 2023
Reduced 39.22%
|
|
Thomas J. Lynch Jr.
EVP & Chief Scientific Officer |
45,324 | 23,102 | 22,222 $1.24 Million | 8 |
Apr 03, 2019
Reduced 11.26%
|
|
Dinesh C Paliwal
Director |
13,944 | 0 | 22,109 $1.23 Million | 2 |
Jun 15, 2020
Added 29.33%
|
|
Emmanuel Blin
SVP, Chief Strategy Officer |
28,794 | 9,391 | 20,137 $1.12 Million | 8 |
Mar 10, 2017
Reduced 14.99%
|
|
Karen Murphy Santiago
SVP & Controller |
41,623 | 25,322 | 16,704 $931,582 | 22 |
Mar 14, 2022
Reduced 28.25%
|
|
Adam Dubow
SVP,ChiefCompliance&EthicsOff. |
16,222 | 17,143 | 13,777 $768,343 | 13 |
Jul 30, 2021
Reduced 15.18%
|
|
Julia A Haller
Director |
11,210 | 0 | 13,619 $759,531 | 6 |
Jun 03, 2022
Added 17.8%
|
|
Michael W Bonney
Director |
8,349 | 0 | 12,501 $697,180 | 6 |
Jun 13, 2021
Added 6.73%
|
|
Phil M Holzer
SVP and Controller |
5,520 | 3,071 | 12,460 $694,894 | 2 |
Mar 10, 2024
Reduced 7.37%
|
|
Robert J Bertolini
Director |
11,000 | 0 | 11,397 $635,610 | 1 |
Jul 31, 2019
Added 49.11%
|
|
Robert M Plenge
EVP, Chief Research Officer |
9,759 | 5,760 | 11,315 $631,037 | 5 |
Mar 10, 2024
Reduced 11.26%
|
|
Joseph Eid
SVP,Head Glob. Medical Affairs |
18,784 | 12,769 | 9,485 $528,978 | 14 |
Jun 03, 2021
Reduced 7.22%
|
|
Adam Lenkowsky
EVP, Chief Commercial Officer |
16,093 | 9,443 | 6,650 $370,870 | 4 |
Mar 10, 2024
Reduced 32.73%
|
|
Paul Biondi
SVP, Head of Strategy & BD |
11,264 | 5,050 | 6,214 $346,554 | 8 |
Oct 02, 2019
Reduced 3.16%
|
|
Karin Shanahan
EVP, Glob. Prod. Dev. & Supply |
9,138 | 3,802 | 5,336 $297,588 | 6 |
Apr 01, 2024
Reduced 18.31%
|
|
Gregory Scott Meyers
EVP, Chief Digital & Tech Off. |
8,014 | 2,728 | 5,286 $294,800 | 6 |
Feb 01, 2024
Reduced 12.48%
|
|
Cari Gallman
EVP, Corporate Affairs |
8,380 | 3,567 | 5,019 $279,909 | 6 |
Oct 02, 2024
Reduced 24.72%
|
|
Michelle Weese
EVP, Corporate Affairs |
5,411 | 1,958 | 3,453 $192,573 | 6 |
Jul 01, 2023
Reduced 16.49%
|
|
Ahn Amanda Poole
EVP, Chief Human Resources |
5,458 | 3,034 | 2,424 $135,186 | 2 |
Mar 10, 2024
Reduced 28.71%
|
|
Lynelle Hoch
President, Cell Therapy Org. |
4,351 | 2,625 | 1,726 $96,259 | 2 |
Mar 10, 2024
Reduced 34.7%
|
|
Sharon Greenlees
SVP & Controller |
1,017 | 408 | 609 $33,963 | 2 |
May 02, 2023
Reduced 16.35%
|
|
Paul Von Autenried
EVP, Chief Information Officer |
221,220 | 278,440 | 0 $0 | 19 |
Jul 30, 2021
Reduced 100.0%
|
|
Lewis B Campbell
Director |
2,500 | 2,500 | 0 $0 | 2 |
Mar 08, 2016
Reduced 100.0%
|